Table 1.

Sensitivities, specificities, positive (LR+), and negative likelihood ratios (LR−) for temporal artery ultrasonography (TA-US) findings versus TAB-proven or clinically defined GCA. Values in parentheses are the 95% CI.

TAB-Proven GCAClinically Defined GCA
Sensitivity, %Specificity, %LR+LR−Sensitivity, %Specificity, %LR+LR−
Doppler and duplex TA-US, n = 77
  Stenosis62 (36–82)70 (58–80)2.1 (1.2–3.7)0.5 (0.3–1.1)47 (27–68)69 (56–79)1.5 (0.8–2.8)0.8 (0.5–1.2)
  Occlusion15 (4–42)84 (74–91)1.0 (0.2–4.0)1.0 (0.8–1.3)11 (3–31)83 (71–90)0.6 (0.1–2.5)1.1 (0.9–1.3)
  Any stenosis and/or occlusion69 (42–87)59 (47–71)1.7 (1.1–2.7)0.5 (0.2–1.2)53 (32–73)57 (44–69)1.2 (0.7–2.1)0.8 (0.5–1.4)
  Any stenosis and/or occlusion (seen bilaterally)23 (8–50)88 (77–94)1.8 (0.6–6.0)0.9 (0.6–1.2)16 (6–38)86 (75–93)1.1 (0.3–3.9)1.0 (0.8–1.2)
Duplex TA-US, n = 31
  Halo sign17 (3–56)100 (87–100)Infinite (NA)0.8 (0.6–1.2)10 (2–40)100 (85–100)Infinite (NA)0.9 (0.7–1.1)
  Any stenosis, occlusion, and/or halo50 (19–81)72 (52–86)1.8 (0.6–4.9)0.7 (0.3–1.6)20 (6–51)62 (41–79)0.5 (0.1–2.0)1.3 (0.8–2.0)
  Any stenosis, occlusion, and/or halo (seen bilaterally)17 (3–56)96 (80–99)4.2 (0.3–57.5)0.9 (0.6–1.3)10 (2–40)95 (77–99)2.1 (0.1–30.3)0.9 (0.8–1.2)
  • NA: not applicable. TAB: temporal artery biopsy; GCA: giant cell arteritis.